TRVI Trevi Therapeutics, Inc. - Common Stock
$18.83
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$7–$20
90% of range
分析师评级
BUY
18 analysts
目标价
$28
+50% upside
P/E (TTM)
-58.8
ROE
-22.4%
净利润率
—
TRVI 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$18.83
市值
$2.42B
P/E (TTM)
-58.8
每股收益 (TTM)
$-0.32
营收 (TTM)
—
股息收益率
—
ROE
-22.4%
负债/权益
—
52周区间
$7 – $20
TRVI 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-0.32
2021-12-31
→
2025-12-31
自由现金流
$-42M
2019-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
TRVI
同行中位数
P/E (TTM)
-58.8
29.4
P/B (市净率)
13.2
6.5
Price / FCF (股价/自由现金流)
-57.4
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
TRVI
同行中位数
ROA
-28.1%
-8.2%
ROE
-22.4%
-19.4%
ROIC
-26.9%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
TRVI
同行中位数
Current Ratio (流动比率)
19.7
3.6
Quick Ratio (速动比率)
19.3
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
TRVI
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
TRVI
同行中位数
TRVI 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
18 位分析师
- 强烈买入 6 33.3%
- 买入 11 61.1%
- 持有 1 5.6%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
11 位分析师 · 2026-08-16
中位数
$25.00
平均值
$28.18
← 低于所有目标
$18.83
最低
$23.00
最高
$40.00
中位数目标
$25.00
+32.8%
平均目标
$28.18
+49.7%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.02%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.11 | $-0.11 | 0.00% |
| 2026年3月31日 | $-0.09 | $-0.08 | -0.01% |
| 2025年12月31日 | $-0.06 | $-0.10 | 0.04% |
| 2025年9月30日 | $-0.08 | $-0.10 | 0.02% |
| 2025年6月30日 | $-0.09 | $-0.10 | 0.01% |
| 2025年3月31日 | $-0.09 | $-0.12 | 0.03% |
| 2024年12月31日 | $-0.11 | $-0.12 | 0.01% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | — |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $33M | $39M | $24M | $20M | $23M | $22M | $19M | $14M | |
| SG&A Expense | $16M | $12M | $10M | $10M | $9M | $10M | $7M | $4M | |
| Operating Expenses | $49M | $52M | $34M | $30M | $32M | $32M | $27M | $18M | |
| Operating Income | $-49M | $-52M | $-34M | $-30M | $-32M | $-32M | $-27M | $-18M | |
| Interest Expense | · | · | $391.0K | $1M | $1M | $456.0K | · | $174.0K | |
| Interest Income | $7M | $4M | $5M | · | · | · | · | · | |
| Other Non-op | $-31.0K | $-15.0K | $469.0K | $289.0K | $-375.0K | $-287.0K | $577.0K | $-2M | |
| Pretax Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| Income Tax | $-64.0K | $-30.0K | $-32.0K | $-36.0K | $-21.0K | $-18.0K | $-18.0K | $-124.0K | |
| Net Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| EPS (Basic) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| EPS (Diluted) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| Shares (Basic) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| Shares (Diluted) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| EBITDA | $-49M | $-51M | $-34M | $-30M | $-32M | $-32M | $-27M | · |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $34M | $32M | $13M | $37M | $45M | $57M | $7M | |
| Short-term Investments | $169M | $74M | $51M | $108M | · | · | · | · | |
| Prepaid Expense | $1M | $939.0K | $4M | $795.0K | $886.0K | $1M | $2M | $1M | |
| Other Current Assets | $2M | $867.0K | $955.0K | $1M | $241.0K | $265.0K | · | · | |
| Current Assets | $192M | $109M | $88M | $123M | $38M | $46M | $60M | $9M | |
| PP&E (Net) | $178.0K | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K | |
| PP&E (Gross) | $537.0K | $385.0K | $350.0K | $395.0K | $235.0K | $235.0K | $203.0K | $195.0K | |
| Accum. Depreciation | $359.0K | $228.0K | $134.0K | $225.0K | $182.0K | $132.0K | $85.0K | $46.0K | |
| Other Non-current Assets | $928.0K | $243.0K | $297.0K | $205.0K | $334.0K | $532.0K | · | · | |
| Total Assets | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $603.0K | |
| Accrued Liabilities | $6M | $7M | $4M | $4M | $4M | $3M | $4M | $2M | |
| Current Liabilities | $10M | $11M | $6M | $13M | $13M | $6M | $5M | $3M | |
| Capital Leases | $446.0K | $747.0K | $1M | $2.0K | $24.0K | $144.0K | $257.0K | $46.0K | |
| Other Non-current Liabilities | · | · | · | $3.0K | · | · | · | · | |
| Total Liabilities | $10M | $11M | $7M | $16M | $21M | $20M | · | · | |
| Common Stock | $128.0K | $94.0K | $68.0K | $60.0K | $29.0K | $19.0K | $18.0K | $4.0K | |
| Paid-in Capital | $513M | $387M | $322M | $318M | $198M | $174M | $169M | · | |
| Retained Earnings | $-330M | $-287M | $-239M | $-210M | $-181M | $-147M | $-114M | $-109M | |
| AOCI | $148.0K | $61.0K | $-29.0K | $-122.0K | · | · | · | · | |
| Stockholders' Equity | $183M | $100M | $83M | $107M | $17M | $27M | $55M | $-109M | |
| Liabilities + Equity | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Shares Outstanding | 128,306,056 | 93,602,631 | 68,283,699 | 59,943,430 | 28,505,804 | 18,546,786 | 17,834,570 | 438,600 |
现金流 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $144.0K | $147.0K | $123.0K | $43.0K | · | · | · | · | |
| Stock-based Comp | $5M | $4M | $2M | $2M | $3M | $2M | $1M | $496.0K | |
| Other Non-cash | $-5M | $6M | $-5M | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-38M | $-32M | $-28M | $-29M | $-29M | $-23M | $-18M | |
| CapEx | $12.0K | $35.0K | $137.0K | $159.0K | · | $32.0K | $9.0K | $158.0K | |
| Investing Cash Flow | $-94M | $-22M | $59M | $-107M | · | $-32.0K | $-9.0K | $-158.0K | |
| Debt Issued | · | · | · | · | · | $14M | · | · | |
| Net Debt Issued | · | · | · | $-6M | · | $14M | · | · | |
| Financing Cash Flow | $121M | $61M | $-8M | $111M | $21M | $17M | $73M | $4M | |
| Net Change in Cash | $-15M | $2M | $20M | $-24M | $-8M | $-12M | $50M | $-15M | |
| Taxes Paid | $-33.0K | $-32.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-42M | $-38M | $-32M | $-28M | · | $-29M | $-23M | · | |
| Levered FCF | · | · | $-32M | $-29M | · | $-29M | · | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -28.1% | -47.8% | -27.4% | -36.1% | -79.3% | -61.2% | -73.9% | · | |
| ROE | -22.4% | -60.4% | -33.8% | -26.8% | -238.5% | -104.2% | -45.2% | · | |
| ROIC | -26.9% | -51.7% | -41.0% | -27.8% | -190.1% | -119.0% | -48.8% | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 | 8.3 | 11.5 | · | |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 | 8.1 | 11.0 | · | |
| Interest Coverage | · | · | -86.8 | -25.7 | -27.0 | -71.2 | · | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | · | |
| Market Cap | $1.61B | $386M | $92M | $116M | $22M | $45M | $67M | · | |
| P/E | -39.1 | -8.8 | -4.6 | -4.3 | -0.5 | · | · | · | |
| P/B | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | 1.2 | · | |
| P / Tangible Book | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | · | · | |
| P / Cash Flow | -38.2 | -10.1 | -2.9 | -4.1 | -0.8 | -1.5 | -2.9 | · | |
| P / FCF | -38.2 | -10.1 | -2.9 | -4.1 | · | -1.5 | -2.9 | · | |
| Earnings Yield | -2.6% | -11.4% | -21.6% | -23.3% | -190.5% | · | · | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $10M | $6M | $10M | $9M | $8M | $9M | $11M | $10M | $9M | $7M | $6M | $6M | $5M | $4M | $6M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | |
| Operating Expenses | $21M | $15M | $10M | $14M | $14M | $11M | $12M | $14M | $13M | $12M | $9M | $9M | $8M | $8M | $7M | $8M | |
| Operating Income | $-21M | $-15M | $-10M | $-14M | $-14M | $-11M | $-12M | $-14M | $-13M | $-12M | $-9M | $-9M | $-8M | $-8M | $-7M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1.0K | $1.0K | · | $3.0K | $153.0K | $231.0K | $274.0K | $292.0K | |
| Interest Income | $3M | $2M | $2M | $2M | $1M | $1M | $843.0K | $826.0K | $935.0K | $998.0K | $1M | $1M | · | · | · | · | |
| Other Non-op | $-3.0K | $4.0K | $-16.0K | $-2.0K | $-7.0K | $-6.0K | $2.0K | $-11.0K | $-5.0K | $-1.0K | $-3.0K | $154.0K | $153.0K | $165.0K | $702.0K | $132.0K | |
| Pretax Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| Income Tax | $-19.0K | $-20.0K | $-17.0K | $-15.0K | $-21.0K | $-11.0K | $17.0K | $-31.0K | $-8.0K | $-8.0K | $18.0K | $-13.0K | $-30.0K | $-7.0K | $-20.0K | $-7.0K | |
| Net Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| EPS (Basic) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| EPS (Diluted) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| Shares (Basic) | 156,602,158 | 145,592,901 | -258,318,929 | 145,104,986 | 130,350,391 | 117,610,750 | -199,869,140 | 101,282,228 | 101,041,573 | 99,517,212 | -197,601,417 | 99,325,540 | 98,698,579 | 98,610,671 | -94,705,331 | 68,898,810 | |
| Shares (Diluted) | 156,602,158 | 145,592,901 | -258,318,929 | 145,104,986 | 130,350,391 | 117,610,750 | -199,869,140 | 101,282,228 | 101,041,573 | 99,517,212 | -197,601,417 | 99,325,540 | 98,698,579 | 98,610,671 | -94,705,331 | 68,898,810 | |
| EBITDA | $-21M | $-15M | · | $-14M | $-14M | $-11M | · | $-14M | $-13M | $-12M | · | $-9M | $-8M | $-8M | · | $-8M |
资产负债表 23
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $19M | $19M | $57M | $117M | $19M | $34M | $16M | $13M | $14M | $32M | $26M | $14M | $12M | $13M | $67M | |
| Short-term Investments | $265M | $152M | $169M | $138M | $87M | $84M | $74M | $49M | $57M | $59M | $51M | $63M | $80M | $100M | $108M | $59M | |
| Prepaid Expense | $4M | $2M | $1M | $1M | $2M | $2M | $939.0K | $1M | $2M | $3M | $4M | $4M | $3M | $1M | $795.0K | $1M | |
| Other Current Assets | $3M | $2M | $2M | $2M | $2M | $834.0K | $867.0K | $667.0K | $830.0K | $721.0K | $955.0K | $1M | $2M | $2M | $1M | $421.0K | |
| Current Assets | $326M | $176M | $192M | $198M | $207M | $106M | $109M | $67M | $72M | $77M | $88M | $94M | $99M | $114M | $123M | $127M | |
| PP&E (Net) | $336.0K | $265.0K | $178.0K | $213.0K | $239.0K | $277.0K | $157.0K | $174.0K | $198.0K | $204.0K | $216.0K | $238.0K | $225.0K | $245.0K | $170.0K | $68.0K | |
| PP&E (Gross) | · | · | $537.0K | · | · | · | $385.0K | · | · | · | $350.0K | · | · | · | $395.0K | · | |
| Accum. Depreciation | · | · | $359.0K | · | · | · | $228.0K | · | · | · | $134.0K | · | · | · | $225.0K | · | |
| Other Non-current Assets | $4M | $3M | $928.0K | $103.0K | $68.0K | $241.0K | $243.0K | $256.0K | $273.0K | $311.0K | $297.0K | $297.0K | $68.0K | $225.0K | $205.0K | $922.0K | |
| Total Assets | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $3M | $2M | |
| Accrued Liabilities | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $5M | $3M | $4M | $4M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $9M | $7M | $10M | $9M | $9M | $7M | $11M | $9M | $7M | $5M | $6M | $5M | $5M | $13M | $13M | $15M | |
| Capital Leases | $276.0K | $364.0K | $446.0K | $527.0K | $605.0K | $681.0K | $747.0K | $816.0K | $884.0K | $949.0K | $1M | $1M | $1M | $1M | $2.0K | $2.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $15.0K | |
| Total Liabilities | $9M | $7M | $10M | $10M | $10M | $8M | $11M | $10M | $8M | $6M | $7M | $6M | $6M | $14M | $16M | $18M | |
| Common Stock | $142.0K | $128.0K | $128.0K | $128.0K | $122.0K | $100.0K | $94.0K | $75.0K | $73.0K | $69.0K | $68.0K | $64.0K | $63.0K | $60.0K | $60.0K | $58.0K | |
| Paid-in Capital | $683M | $515M | $513M | $511M | $508M | $397M | $387M | $334M | $329M | $322M | $322M | $321M | $319M | $318M | $318M | $315M | |
| Retained Earnings | $-361M | $-343M | $-330M | $-321M | $-310M | $-297M | $-287M | $-276M | $-262M | $-250M | $-239M | $-231M | $-224M | $-216M | $-210M | $-205M | |
| AOCI | $-425.0K | $-190.0K | $148.0K | $30.0K | $24.0K | $73.0K | $61.0K | $139.0K | $-84.0K | $-67.0K | $-29.0K | $-217.0K | $-248.0K | $-88.0K | $-122.0K | $-263.0K | |
| Stockholders' Equity | $322M | $172M | $183M | $190M | $198M | $99M | $100M | $59M | $66M | $72M | $83M | $90M | $95M | $102M | $107M | $110M | |
| Liabilities + Equity | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Shares Outstanding | 142,420,883 | 128,411,048 | 128,306,056 | 128,215,113 | 121,775,753 | 99,892,915 | 93,602,631 | 75,454,375 | 72,591,917 | 68,960,167 | 68,283,699 | 63,855,330 | 63,098,455 | 60,065,408 | 59,943,430 | 58,322,517 |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $34.0K | $31.0K | $38.0K | $38.0K | $37.0K | $38.0K | $36.0K | $38.0K | $35.0K | $35.0K | $35.0K | $34.0K | $19.0K | $15.0K | $9.0K | |
| Stock-based Comp | $3M | $2M | $1M | $1M | $1M | $1M | $916.0K | $822.0K | $1M | $723.0K | $609.0K | $530.0K | $530.0K | $578.0K | $501.0K | $569.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-4M | · | · | · | $-323.0K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-17M | $-17M | $-8M | $-11M | $-10M | $-13M | $-10M | $-10M | $-9M | $-10M | $-6M | $-7M | $-10M | $-8M | $-6M | $-9M | |
| CapEx | $124.0K | $102.0K | $0 | $12.0K | · | · | $7.0K | $0 | · | · | $22.0K | $18.0K | $40.0K | $57.0K | $116.0K | · | |
| Investing Cash Flow | $-112M | $17M | $-31M | $-51M | $-3M | $-10M | $-24M | $8M | $3M | $-8M | $13M | $18M | $20M | $9M | $-48M | $-5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Financing Cash Flow | $164M | $222.0K | $284.0K | $2M | $110M | $9M | $51M | $5M | $5M | $-28.0K | $-54.0K | $2M | $-8M | $-2M | $652.0K | $55M | |
| Net Change in Cash | $35M | $498.0K | $-38M | $-60M | $98M | $-15M | $18M | $3M | $-848.0K | $-19M | $6M | $12M | $2M | $-938.0K | $-54M | $42M | |
| Free Cash Flow | · | $-17M | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.6% | -9.2% | · | -8.8% | -8.7% | -11.1% | · | -16.1% | -14.1% | -11.2% | · | -6.9% | -7.8% | -8.7% | · | -10.3% | |
| ROE | -6.9% | -9.7% | · | -9.5% | -9.3% | -12.0% | · | -17.8% | -15.3% | -12.5% | · | -7.7% | -9.2% | -11.4% | · | -13.6% | |
| ROIC | -6.4% | -8.6% | · | -7.3% | -6.9% | -11.5% | · | -23.8% | -20.1% | -16.4% | · | -10.1% | -8.8% | -7.4% | · | -7.6% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.3 | 24.8 | · | 21.9 | 22.4 | 15.4 | · | 7.4 | 10.7 | 14.6 | · | 18.2 | 21.1 | 8.7 | · | 8.7 | |
| Quick Ratio | 36.5 | 24.1 | · | 21.6 | 22.1 | 15.0 | · | 7.2 | 10.3 | 13.8 | · | 17.2 | 20.0 | 8.4 | · | 8.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -13289.0 | -11906.0 | · | -3015.0 | -54.8 | -32.7 | · | -28.8 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-55M | $-48M | · | $-48M | $-48M | $-47M | · | $-44M | $-38M | $-32M | · | $-30M | $-30M | $-30M | · | $-31M | |
| Market Cap | $2.66B | $1.53B | · | $1.17B | $666M | $628M | · | $252M | $216M | $238M | · | $139M | $151M | $111M | · | $90M | |
| P/E | -50.4 | -34.1 | · | -23.5 | -12.7 | -14.0 | · | -7.6 | -7.8 | -10.8 | · | -6.6 | -6.1 | -3.3 | · | -1.8 | |
| P/B | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Tangible Book | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Cash Flow | · | -91.8 | · | · | · | -46.6 | · | · | · | -22.7 | · | · | · | -13.6 | · | · | |
| P / FCF | · | -91.2 | · | · | · | · | · | · | · | · | · | · | · | -13.5 | · | · | |
| Earnings Yield | -2.0% | -2.9% | · | -4.3% | -7.9% | -7.1% | · | -13.2% | -12.8% | -9.3% | · | -15.1% | -16.3% | -30.3% | · | -54.5% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-43M | $-48M | $-29M | $-29M | $-34M |
| 稀释后每股收益 (EPS) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 |
| 速动比率 | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-42M | $-38M | $-32M | $-28M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 229 家申报者 · $2.5B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 49 (+6 与上一季度对比) | 19 (-5 与上一季度对比) | 77 (+12 与上一季度对比) | 61 (-3 与上一季度对比) | +10.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| NEA Management Company, LLC | $246594552 | 13222228 | 10.04% | 股份 |
| FMR LLC | $199426054 | 10693086 | 8.12% | 股份 |
| Frazier Life Sciences Management, L.P. | $185370687 | 9939447 | 7.54% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $103147089 | 5530675 | 4.20% | 股份 |
| Vivo Capital, LLC | $95015558 | 5094668 | 3.87% | 股份 |
| Woodline Partners LP | $76116860 | 4081333 | 3.10% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $71755577 | 3847484 | 2.92% | 股份 |
| VANGUARD GROUP INC | $70127888 | 5601269 | 2.85% | 股份 |
| Vestal Point Capital, LP | $57815000 | 3100000 | 2.35% | 股份 |
| MPM BIOIMPACT LLC | $57322211 | 3073577 | 2.33% | 股份 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $57269301 | 3070740 | 2.33% | 股份 |
| STATE STREET CORP | $56459425 | 3027315 | 2.30% | 股份 |
| MARSHALL WACE, LLP | $49872655 | 2674137 | 2.03% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $49609000 | 2660000 | 2.02% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $46749639 | 2506090 | 1.90% | 股份 |
| Rubric Capital Management LP | $46709167 | 2504513 | 1.90% | 股份 |
| Artia Global Partners LP | $41232390 | 2210852 | 1.68% | 股份 |
| ACORN CAPITAL ADVISORS, LLC | $40001341 | 2144844 | 1.63% | 股份 |
| First Light Asset Management, LLC | $39113060 | 2097215 | 1.59% | 股份 |
| Pictet Asset Management Holding SA | $37557109 | 2013786 | 1.53% | 股份 |
| Logos Global Management LP | $35062000 | 1880000 | 1.43% | 股份 |
| Affinity Asset Advisors, LLC | $33573208 | 1800172 | 1.37% | 股份 |
| EMERALD ADVISERS, LLC | $33525445 | 1797611 | 1.36% | 股份 |
| Siren, L.L.C. | $33325070 | 1786867 | 1.36% | 股份 |
| Pivotal bioVenture Partners Investment Advisor LLC | $32500833 | 1742672 | 1.32% | 股份 |
| VIKING GLOBAL INVESTORS LP | $28807611 | 1544644 | 1.17% | 股份 |
| Assenagon Asset Management S.A. | $28447106 | 1525314 | 1.16% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $28100554 | 2355453 | 1.14% | 股份 |
| BANK OF AMERICA CORP /DE/ | $26936643 | 1444324 | 1.10% | 股份 |
| ORBIMED ADVISORS LLC | $26674964 | 1430293 | 1.09% | 股份 |
| Jones Hill Capital LP | $24976304 | 1339212 | 1.02% | 股份 |
| NAN FUNG TRINITY (HK) LTD | $22634013 | 1213620 | 0.92% | 股份 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $22584497 | 1210965 | 0.92% | 股份 |
| Soleus Capital Management, L.P. | $21999876 | 1179618 | 0.90% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21948663 | 1176872 | 0.89% | 股份 |
| BARCLAYS PLC | $21199213 | 1136687 | 0.86% | 股份 |
| GOLDMAN SACHS GROUP INC | $19825528 | 1063031 | 0.81% | 股份 |
| Saturn V Capital Management LP | $19620602 | 1052043 | 0.80% | 股份 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $19359763 | 1038057 | 0.79% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18138990 | 972600 | 0.74% | 买入期权 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18004747 | 965402 | 0.73% | 股份 |
| Candriam S.C.A. | $18002647 | 966219 | 0.73% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $17533126 | 940114 | 0.71% | 股份 |
| Balyasny Asset Management L.P. | $15760873 | 845087 | 0.64% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $15685750 | 841059 | 0.64% | 股份 |
| Burkehill Global Management, LP | $13521250 | 725000 | 0.55% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $12646472 | 678095 | 0.51% | 股份 |
| AMERIPRISE FINANCIAL INC | $11572904 | 620531 | 0.47% | 股份 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $9776778 | 524224 | 0.40% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $9306891 | 499029 | 0.38% | 股份 |
| PEREGRINE CAPITAL MANAGEMENT LLC | $8286382 | 444310 | 0.34% | 股份 |
| KVP Capital Advisors, LP | $7721100 | 414000 | 0.31% | 股份 |
| Ensign Peak Advisors, Inc | $7388626 | 396173 | 0.30% | 股份 |
| Octagon Capital Advisors LP | $5874750 | 315000 | 0.24% | 股份 |
| Opaleye Management Inc. | $5781500 | 310000 | 0.24% | 股份 |
| BlackRock, Inc. | $5355515 | 287159 | 0.22% | 股份 |
| Informed Momentum Co LLC | $4935368 | 264631 | 0.20% | 股份 |
| FIFTH THIRD BANCORP | $4861011 | 260644 | 0.20% | 股份 |
| Rock Springs Capital Management LP | $4849000 | 260000 | 0.20% | 股份 |
| Trexquant Investment LP | $4523315 | 242537 | 0.18% | 股份 |
| Walleye Capital LLC | $4513058 | 241987 | 0.18% | 股份 |
| F/m Investments LLC | $4367979 | 234208 | 0.18% | 股份 |
| JANE STREET GROUP, LLC | $3761705 | 201700 | 0.15% | 买入期权 |
| Integral Health Asset Management, LLC | $3730000 | 200000 | 0.15% | 股份 |
| Swiss National Bank | $3586395 | 192300 | 0.15% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $3398683 | 182235 | 0.14% | 股份 |
| Nuveen, LLC | $3292602 | 176547 | 0.13% | 股份 |
| SEVEN GRAND MANAGERS, LLC | $2797500 | 150000 | 0.11% | 股份 |
| RHUMBLINE ADVISERS | $2470423 | 132463 | 0.10% | 股份 |
| TRUST CO OF TOLEDO NA /OH/ | $2312637 | 124002 | 0.09% | 股份 |
| D. E. Shaw & Co., Inc. | $2286415 | 122596 | 0.09% | 股份 |
| CITADEL ADVISORS LLC | $2170860 | 116400 | 0.09% | 买入期权 |
| Harvest Investment Services, LLC | $2146690 | 115104 | 0.09% | 股份 |
| WINTON GROUP Ltd | $1992790 | 106852 | 0.08% | 股份 |
| Bank of New York Mellon Corp | $1959854 | 105086 | 0.08% | 股份 |
| Qube Research & Technologies Ltd | $1906515 | 102226 | 0.08% | 股份 |
| LMR Partners LLP | $1865000 | 100000 | 0.08% | 股份 |
| OPPENHEIMER & CO INC | $1860729 | 99771 | 0.08% | 股份 |
| SIMPLEX TRADING, LLC | $1819438 | 97557 | 0.07% | 股份 |
| WEXFORD CAPITAL LP | $1692525 | 90752 | 0.07% | 股份 |
| Erste Asset Management GmbH | $1676700 | 90000 | 0.07% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1543343 | 82753 | 0.06% | 股份 |
| Campbell & CO Investment Adviser LLC | $1526950 | 81874 | 0.06% | 股份 |
| J. Goldman & Co LP | $1510613 | 80998 | 0.06% | 股份 |
| PFS Partners, LLC | $1473350 | 79000 | 0.06% | 股份 |
| Schonfeld Strategic Advisors LLC | $1416838 | 75970 | 0.06% | 股份 |
| Checkpoint Capital L.P. | $1398750 | 75000 | 0.06% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $1379690 | 73978 | 0.06% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1348320 | 72296 | 0.05% | 股份 |
| CITIGROUP INC | $1329540 | 71289 | 0.05% | 股份 |
| FRED ALGER MANAGEMENT, LLC | $1240039 | 66490 | 0.05% | 股份 |
| SECTORAL ASSET MANAGEMENT INC | $1223365 | 65596 | 0.05% | 股份 |
| Vanguard Global Advisers, LLC | $1198785 | 64278 | 0.05% | 股份 |
| Steward Partners Investment Advisory, LLC | $1186140 | 63600 | 0.05% | 股份 |
| LPL Financial LLC | $1183324 | 63449 | 0.05% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $1176964 | 63108 | 0.05% | 股份 |
| MetLife Investment Management, LLC | $1165494 | 62493 | 0.05% | 股份 |
| XTX Topco Ltd | $1154360 | 61896 | 0.05% | 股份 |
| WealthTrust Axiom LLC | $1146975 | 61500 | 0.05% | 股份 |
| MAI Capital Management | $1046825 | 56130 | 0.04% | 股份 |
公司内部人士 37 位内幕人士 · 13 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Jennifer L Good | President & CEO | 2026年2月19日 A | 213313 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 2026年1月8日 A | — | 0 | 0 | $0 |
| Lisa Delfini | Chief Financial Officer | 2025年5月31日 A | 64660 | 0 | 0 | $0 |
| Christopher Seiter | Chief Financial Officer | 2021年2月17日 A | — | 0 | 0 | $0 |
| Farrell Simon | Chief Commercial Officer | 2026年2月19日 A | 76900 | 0 | 0 | $0 |
| Christopher Galletta | Controller and Principal Accounting Officer | 2026年2月19日 A | 26095 | 0 | 0 | $0 |
| James V Cassella | Chief Development Officer | 2026年2月19日 A | — | 0 | 0 | $0 |
| Thomas Sciascia | Chief Scientific Officer | 2026年2月19日 A | 221373 | 0 | 0 | $0 |
| David J Clark | Chief Medical Officer | 2024年2月15日 A | — | 0 | 0 | $0 |
| William P Forbes | Chief Development Officer | 2022年6月29日 A | — | 0 | 0 | $0 |
| Frank P Muscolo | Controller | 2021年2月17日 A | — | 0 | 0 | $0 |
| Helena Brett-Smith | Chief Development Officer | 2020年2月13日 A | — | 0 | 0 | $0 |
| Yann Mazabraud | Chief Commercial Officer and Head of International | 2020年2月13日 A | — | 0 | 0 | $0 |
| Michael Thomas Heffernan | 董事 | 2026年6月3日 A | 6351 | 0 | 0 | $0 |
| David P Meeker | 董事 | 2026年6月3日 A | 352489 | 0 | 0 | $0 |
| Edward T. Mathers | 董事 | 2026年6月3日 A | 948948 | 0 | 0 | $0 |
| Dominick Colangelo | 董事 | 2026年6月3日 A | — | 0 | 0 | $0 |
| Anne Vanlent | 董事 | 2026年6月3日 A | 25983 | 0 | 0 | $0 |
| Mette Kirstine Agger | 董事 | 2019年5月9日 C | 1151544 | 0 | 0 | $0 |
| Anna Guyer Mitsak | 董事 | 2019年5月7日 A | — | 0 | 0 | $0 |
| Eran Nadav | 董事 | 2019年5月7日 A | — | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10% 所有者 | 2022年4月11日 P | 948948 | 0 | 0 | $0 |
| Ali Behbahani | 10% 所有者 | 2022年4月11日 P | 948948 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10% 所有者 | 2022年4月11日 P | 948948 | 0 | 0 | $0 |
| Peter W. Sonsini | 10% 所有者 | 2022年4月11日 P | 948948 | 0 | 0 | $0 |
| Paul Walker | 10% 所有者 | 2022年4月11日 P | 948948 | 0 | 0 | $0 |
| Forest Baskett | 10% 所有者 | 2022年4月11日 P | 10421428 | 0 | 0 | $0 |
| Scott D. Sandell | 10% 所有者 | 2022年4月11日 P | 948948 | 0 | 0 | $0 |
| Joshua Makower | 10% 所有者 | 2020年4月3日 X | 5937998 | 0 | 0 | $0 |
| Debra A Drake | 10% 所有者 | 2019年5月9日 C | 10399 | 0 | 0 | $0 |
| Richard King Mellon Foundation | 10% 所有者 | 2019年5月9日 C | 347157 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10% 所有者 | 2019年5月9日 C | 1151544 | 0 | 0 | $0 |
| Peter F Drake | 10% 所有者 | 2019年5月9日 C | 62540 | 0 | 0 | $0 |
| William J Oshea | 10% 所有者 | 2019年5月9日 C | 114080 | 0 | 0 | $0 |
| David M Mott | 10% 所有者 | 2019年5月9日 C | 4438562 | 0 | 0 | $0 |
| Peter J Barris | 10% 所有者 | 2019年5月9日 C | 4438562 | 0 | 0 | $0 |
| Carmen Chang | — | 2022年4月11日 P | 948948 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×10 申报 | 2026年5月7日 | 10.50% | 修订 | 被动投资 | SEC |
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Richard J. Lim, Claudio Nessi, Anne-Mari Paster, Otello Stampacchia | 2019年5月20日 | — | 初始申报 | 董事会活动 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 34 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3.12% | 231602 NS | 2026年5月31日 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.54% | 14451 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.09% | 4742 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.04% | 41397 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.03% | 554292 NS | 2026年5月31日 | N-PORT |
| ITWO · ProShares Trust | 0.03% | 4499 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.03% | 18627 NS | 2026年5月31日 | N-PORT |
| UWM · ProShares Trust | 0.02% | 3519 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 40477 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.01% | 3558 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 3851 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 89 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 41948 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 59480 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IHE · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PTH · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCG · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ESML · iShares Trust | — | — | 2026年8月14日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月5日 | 每日 |
| DWAS · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |